Investor » About Us » Board of Directors

Board of Directors

Dr. Anthony F. Holler
Edward Wright
Dr. Iain Cleator
Todd Patrick
Ian Webb


Dr. Anthony F. Holler, Chairman of the Board

Dr. Holler was appointed Chairman of the Board of CRH Medical Corporation on December 21, 2005. He was one of the original founders of ID Biomedical Corporation and was a member of the Company's Board of Directors since inception. Dr. Holler has held a number of executive positions with ID Biomedical, including President and Chief Executive Officer. Prior to founding ID Biomedical, Dr. Holler served as an emergency physician at University Hospital at the University of British Columbia. He is a member of the British Columbia College of Physicians and Surgeons.

Back to topˆ

Edward Wright, Chief Executive Officer, President and Director

Mr. Wright joins CRH Medical from Cartier North America were he held the post of Executive Vice President of Retail for North America. While at Cartier, Mr. Wright was responsible for the development and operations of the entire North American retail division, including implementation of strategic goals, supervision of retail development, and ensuring successful achievement of Cartier’s retail objectives for the North American market segment. Mr. Wright oversaw 34 locations, 180 employees and a revenue increase in excess of 20% over the past year.

Back to topˆ

Dr. Iain Cleator, Director

Iain Cleator, M.D., is Professor Emeritus of Surgery at the University of British Columbia. He currently operates the Cleator Clinic, which he founded in 2003 to care for the many patients afflicted with anorectal disorders. Professor Cleator also founded the G.I. Clinic at St. Paul’s hospital in Vancouver and held many positions there including Head of the G.I. Clinic and Head of Service.  He has carried out more than 13,000 colonoscopies and specialized in gastrointestinal and bariatric surgery during his career. 

Dr. Cleator is a past President of the Canadian Association of Gastroenterologists as well as past President of the Vancouver Medical Association. Dr. Cleator has published more than 100 papers, chapters and articles, and his academic interests include the early detection of colorectal cancer. A 1962 graduate in surgery from Edinburgh University, Dr. Cleator accepted a position as academic surgeon at the University of British Columbia in 1972. 
 
In 2005, Dr. Cleator authored the largest and most comprehensive patient study ever conducted concerning hemorrhoids.  The study involved 5,424 procedures performed on 1,852 patients using the CRH-O’Regan Disposable Hemorrhoid Banding System. To the average surgeon performing 100 procedures per year, this data represents over 54 years of hemorrhoid banding. Notably, the study documents the lowest complication rate ever published: 16 in 5,424 procedures, or 0.3%, which is ten times lower than the standard complication rates previously published over the past 45 years using re-usable instruments.

Back to topˆ

Todd Patrick, Director

Mr. Patrick served as President of ID Biomedical Corporation and was member of its Board of Directors.  He was employed by ID Biomedical Corporation from July 1994 to January 2006, when he resigned upon the completion of ID Biomedical's acquisition by GlaxoSmithKline. Mr. Patrick joined ID Biomedical from the University of California, Los Angeles (UCLA), where, as the Director of the Office of Intellectual Property Administration, he was responsible for patenting and licensing of the intellectual property arising out of UCLA.

Back to topˆ

Ian Webb, Director

Mr. Webb is a partner of the law firm of Borden Ladner Gervais LLP.  His practice focuses on corporate and securities law with an emphasis on the legal requirements of public companies in a wide variety of industry sectors, including biotechnology, mining and forestry.  Mr. Webb obtained a Bachelor of Laws Degree from York University in 1981 and a Master of Science Degree in Theoretical Physics from the University of Saskatchewan in 1976. 

Back to topˆ

 


Business Model Previous: Business Model    Next: Medical Advisory Board Medical Advisory Board